After an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by the board after an accounting scandal at a foreign subsidiary. By forming a coalition with other shareholders, representing a majority of the company’s shares, Emalfarb was able to dismiss the board members who had […]
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Managing suppliers is fraught with challenges. Rare is the executive who has not made a mistake. In this article, I look at some of the most common mistakes—most of which I’ve made myself—and how to avoid them.
For those attending BIO2008, I’ll be speaking on Friday morning: Title: Scientific Communications – Trends and Liabilities Track: Public Relations/Investor Relations Date and Time: Friday, June 20 9:00 AM – 10:30 AM Hope to see you there!
For those attending BIO2008 in San Diego this year, I’ll be signing my books in the BIO bookstore on Wednesday June 18th from 10-11. There will also be a limited number of free copies of the Journal of Commercial Biotechnology, so be sure and show up early!
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in June 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ADALAT CC Bayer Pharms nifedipine 4,892,741 Jun 8, 2008 CAVERJECT IMPULSE Pharmacia And Upjohn alprostadil 4,968,299 Jun 28, 2008 EFFEXOR Wyeth Pharms Inc venlafaxine hydrochloride 4,535,186 Jun 13, 2008 EFFEXOR XR […]
Guest content from Sandy Graham, managing partner at Sequoyah Associates: Can you “see the field” of opportunity? Have your clearly defined your plan to achieve your entrepreneurial dreams? Have you mapped out the strategic direction to attain your plan? Have you envisioned your market and know how to position your business to acquire it? Do […]